112 related articles for article (PubMed ID: 3862612)
1. Eglin c, a pharmacologically active elastase inhibitor.
Schnebli HP; Seemüller U; Fritz H; Maschler R; Liersch M; Virca GD; Bodmer JL; Snider GL; Lucey EC; Stone PG
Eur J Respir Dis Suppl; 1985; 139():66-70. PubMed ID: 3862612
[TBL] [Abstract][Full Text] [Related]
2. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
Renesto P; Ferrer-Lopez P; Chignard M
Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
[TBL] [Abstract][Full Text] [Related]
3. A brief review of the biochemistry and pharmacology of Eglin c, an elastase inhibitor.
Braun NJ; Schnebli HP
Eur J Respir Dis Suppl; 1986; 146():541-7. PubMed ID: 3536558
[TBL] [Abstract][Full Text] [Related]
4. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to serine (pro)enzymes: a comparative thermodynamic study.
Ascenzi P; Aducci P; Amiconi G; Ballio A; Guaragna A; Menegatti E; Schnebli HP; Bolognesi M
J Mol Recognit; 1991; 4(4):113-9. PubMed ID: 1799460
[TBL] [Abstract][Full Text] [Related]
5. Effect of varying the time interval between intratracheal administration of eglin-c and human neutrophil elastase on prevention of emphysema and secretory cell metaplasia in hamsters. With observations on the fate of eglin-c and the effect of repeated instillations.
Lucey EC; Stone PJ; Christensen TG; Breuer R; Calore JD; Snider GL
Am Rev Respir Dis; 1986 Sep; 134(3):471-5. PubMed ID: 3530070
[TBL] [Abstract][Full Text] [Related]
6. Kinetic studies on the interaction of eglin c with human leukocyte elastase and cathepsin G.
Braun NJ; Bodmer JL; Virca GD; Metz-Virca G; Maschler R; Bieth JG; Schnebli HP
Biol Chem Hoppe Seyler; 1987 Apr; 368(4):299-308. PubMed ID: 3649242
[TBL] [Abstract][Full Text] [Related]
7. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to human leukocyte elastase, bovine alpha-chymotrypsin and subtilisin Carlsberg: thermodynamic study.
Ascenzi P; Amiconi G; Menegatti E; Guarneri M; Bolognesi M; Schnebli HP
J Enzyme Inhib; 1988; 2(3):167-72. PubMed ID: 3071573
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of horse leucocyte proteinases by eglin, a proteinase inhibitor from leeches.
Potempa J; Dubin A; Seemüller U; Schnebli HP; Koj A
Biomed Biochim Acta; 1985; 44(2):335-9. PubMed ID: 4004837
[TBL] [Abstract][Full Text] [Related]
9. Eglin-c, a polypeptide derived from the medicinal leech, prevents human neutrophil elastase-induced emphysema and bronchial secretory cell metaplasia in the hamster.
Snider GL; Stone PJ; Lucey EC; Breuer R; Calore JD; Seshadri T; Catanese A; Maschler R; Schnebli HP
Am Rev Respir Dis; 1985 Dec; 132(6):1155-61. PubMed ID: 3907441
[TBL] [Abstract][Full Text] [Related]
10. Effect of the elastase inhibitor eglin C in porcine endotoxin shock.
Siebeck M; Hoffmann H; Weipert J; Fritz H
Circ Shock; 1992 Mar; 36(3):174-9. PubMed ID: 1351797
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte neutral proteinase inhibitor of the pig: modification by eglin C and superoxide dismutase of the response to shock.
Siebeck M; Hoffmann H; Geiger R; Schweiberer L
Prog Clin Biol Res; 1989; 308():945-51. PubMed ID: 2675078
[No Abstract] [Full Text] [Related]
12. Inhibition of human leukocyte elastase bound to elastin: relative ineffectiveness and two mechanisms of inhibitory activity.
Morrison HM; Welgus HG; Stockley RA; Burnett D; Campbell EJ
Am J Respir Cell Mol Biol; 1990 Mar; 2(3):263-9. PubMed ID: 2310584
[TBL] [Abstract][Full Text] [Related]
13. Interaction of Eglin c with polymorphonuclear cells: evidence for binding to the cell surface.
Braun NJ; Schnebli HP
Biol Chem Hoppe Seyler; 1987 Feb; 368(2):155-61. PubMed ID: 3566916
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of the inhibition of human pancreatic elastase by recombinant eglin c. Influence of elastin.
Faller B; Dirrig S; Rabaud M; Bieth JG
Biochem J; 1990 Sep; 270(3):639-44. PubMed ID: 1700695
[TBL] [Abstract][Full Text] [Related]
15. Biochemical properties and possible therapeutic role of the elastase inhibitor eglin C.
Schnebli HP; Seemüller U; Fritz H; Maschler R; Liersch M; Bodmer JL; Virca GD; Lucey EC; Stone PG; Snider GL
Prog Clin Biol Res; 1985; 180():287-90. PubMed ID: 3849804
[No Abstract] [Full Text] [Related]
16. Kinetics of the inhibition of human leucocyte elastase by eglin from the leech Hirudo medicinalis.
Baici A; Seemüller U
Biochem J; 1984 Mar; 218(3):829-33. PubMed ID: 6562888
[TBL] [Abstract][Full Text] [Related]
17. Despite having a common P1 Leu, eglin C inhibits alpha-lytic proteinase a million-fold more strongly than does turkey ovomucoid third domain.
Qasim MA; Van Etten RL; Yeh T; Saunders C; Ganz PJ; Qasim S; Wang L; Laskowski M
Biochemistry; 2006 Sep; 45(38):11342-8. PubMed ID: 16981694
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of peptide fragments related to eglin c and examination of their inhibitory effect on human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
Okada Y; Tsuboi S; Tsuda Y; Nakabayashi K; Nagamatsu Y; Yamamoto J
Biochem Biophys Res Commun; 1989 May; 161(1):272-5. PubMed ID: 2730658
[TBL] [Abstract][Full Text] [Related]
19. Intratracheally-instilled antileukoprotease and alpha 1-proteinase inhibitor: effect on human neutrophil elastase-induced experimental emphysema and pulmonary localization.
Rudolphus A; Kramps JA; Mauve I; Dijkman JH
Histochem J; 1994 Oct; 26(10):817-24. PubMed ID: 7883591
[TBL] [Abstract][Full Text] [Related]
20. Effects of ozone and nitrogen dioxide on human lung proteinase inhibitors.
Johnson DA
Res Rep Health Eff Inst; 1987; (11):5-25. PubMed ID: 3268287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
